In the STEP UP clinical trial, the 7.2 mg dose produced a mean weight loss of 20.7% at 72 weeks, compared with 17.5% at the previously approved 2.4 mg dose and 2.4% with placebo
Brain-targeted liposomes provide effective CNS delivery for neuroactive compounds, while pulmonary and transdermal systems facilitate localized, patient-friendly administration routes
Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects
CrossRef Assessing visibility and bone changes of spinal metastases in CT scans: a comprehensive analysis across diverse cancer types Jung Oh Lee, Dong Hyun Kim, Hee-Dong Chae, Eugene Lee, Ji Hee Kang, Ji Hyun Lee, Hyo Jin Kim, Jiwoon Seo, Jee Won Chai Skeletal Radiology.2024
Pulsatile Release Pattern Ipamorelin produces discrete GH pulses rather than a constant elevation, maintaining the natural rhythm of growth hormone secretion